Track the 경남제약 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 경남제약 has recorded 57 reports. Market capitalisation: €27.4bn. The latest transaction was disclosed on 8 July 2026 (Other). Among the most active insiders: 빌리언스. All data is accessible without an account.
56
Insider Decl.
n/a
Thresholds
n/a
15 ops.
Buy Volume
n/a
25 ops.
Sell Volume
Fundamental score
Ranked 27,147 of 29,064 companies
17.9
score / 100
Value
12
Quality
24
FCF yld-9.9%
Earn yld-30%
EV/EBITDA·
ROE·
Gross mgn27%
Net mgn-16%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.